Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radioimmunoconjugates in the age of modern immuno-oncology.
Nasr D, Kumar PA, Zerdan MB, Ghelani G, Dutta D, Graziano S, Lim SH. Nasr D, et al. Among authors: graziano s. Life Sci. 2022 Dec 1;310:121126. doi: 10.1016/j.lfs.2022.121126. Epub 2022 Oct 27. Life Sci. 2022. PMID: 36309222 Review.
The Lung Microbiota and Lung Cancer: A Growing Relationship.
Bou Zerdan M, Kassab J, Meouchy P, Haroun E, Nehme R, Bou Zerdan M, Fahed G, Petrosino M, Dutta D, Graziano S. Bou Zerdan M, et al. Among authors: graziano s. Cancers (Basel). 2022 Oct 1;14(19):4813. doi: 10.3390/cancers14194813. Cancers (Basel). 2022. PMID: 36230736 Free PMC article. Review.
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer.
Bou Zerdan M, Ashok Kumar P, Barrios DM, Glidden A, Nasr D, Niforatos S, Ghelani G, Leibovitch J, Nasr S, Kc B, Ombada M, Khokhar F, Poudyal B, Bhandari J, Shahnawaz M, Graziano S, Lim SH. Bou Zerdan M, et al. Among authors: graziano s. Front Oncol. 2023 May 12;13:1134824. doi: 10.3389/fonc.2023.1134824. eCollection 2023. Front Oncol. 2023. PMID: 37251929 Free PMC article.
Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.
Graziano SL, Gu L, Wang X, Tatum AH, Vollmer RT, Strauss GM, Kratzke R, Dudek AZ, Vokes EE, Green MR; Cancer and Leukemia Group B; North Central Cancer Treatment Group; Radiation Therapy Oncology Group. Graziano SL, et al. J Thorac Oncol. 2010 Jun;5(6):810-7. doi: 10.1097/jto.0b013e3181d89f95. J Thorac Oncol. 2010. PMID: 20521348 Free PMC article. Clinical Trial.
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.
Reiman T, Lai R, Veillard AS, Paris E, Soria JC, Rosell R, Taron M, Graziano S, Kratzke R, Seymour L, Shepherd FA, Pignon JP, Sève P. Reiman T, et al. Among authors: graziano s. Ann Oncol. 2012 Jan;23(1):86-93. doi: 10.1093/annonc/mdr033. Epub 2011 Apr 6. Ann Oncol. 2012. PMID: 21471564 Free PMC article.
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.
Graziano SL, Lacas B, Vollmer R, Kratzke R, Popper H, Filipits M, Seymour L, Shepherd FA, Rosell R, Veillard AS, Taron M, Pignon JP. Graziano SL, et al. Lung Cancer. 2013 Oct;82(1):149-55. doi: 10.1016/j.lungcan.2013.06.015. Epub 2013 Aug 4. Lung Cancer. 2013. PMID: 23920379 Free PMC article.
286 results